Superworth

uniQure EPS QURE

Diluted earnings per share by quarter and over the last twelve months, from 2016.

Last 12 months, to Jun 30, 2026
−$4.05
Latest quarter, Q2 FY26
−$1.22
Fiscal year 2025
−$3.49

uniQure's earnings per share was −$4.05 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.22.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$3.49n/a
FY2024−$4.93n/a
FY2023−$6.48n/a
FY2022−$2.71−139%
FY2021$6.98n/a
FY2020−$2.82n/a
FY2019−$3.10n/a
FY2018−$2.34n/a
FY2017−$2.91n/a
FY2016−$2.93n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$1.22n/a−$4.05
Q1 FY26−$0.85n/a−$3.52
Q4 FY25−$0.60n/a−$3.49
Q3 FY25−$1.38n/a−$4.39
Q2 FY25−$0.69n/a−$3.92
Q1 FY25−$0.82n/a−$4.39
Q4 FY24−$1.50n/a−$4.93
Q3 FY24−$0.91n/a−$4.96
Q2 FY24−$1.16n/a−$5.93
Q1 FY24−$1.36n/a−$6.21
Q4 FY23−$1.53−1120%−$6.48
Q3 FY23−$1.88n/a−$4.80

Against its peers

Companies in Drug Manufacturers - General nearest uniQure's size, closest first, today.

CompanyEPS, 12 monthsGrowth
QUREuniQure−$4.05
PAHCPhibro Animal Health$2.44+107% a year
ANABAnaptysbio$4.57
PCRXPacira BioSciences$0.35
ANIPANI Pharmaceuticals$4.70
OMEROmeros$1.52
HRMYHarmony Biosciences$3.09−0% a year
AMPHAmphastar Pharmaceuticals$1.70−36% a year
PBHPrestige Consumer Healthcare$3.57−16% a year
NRIXNurix Therapeutics$2.31
ABUSArbutus Biopharma$0.78
Peer median$2.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on uniQure

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.